ArticleJournal of surgical case reports2026
Splenic-preserving total duodenopancreatectomy and a conservative postoperative management: a case report.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is aggressive. Tumors in the isthmus or body may require extended resection. Splenectomy is common, but spleen preservation can reduce hematologic and infectious morbidity while risking splenic ischemia. A 65-year-old man with insulin-treated type 2 diabetes and mid-body PDAC underwent neoadjuvant chemotherapy and laparoscopic spleen-preserving total duodenopancreatectomy. The patient was admitted in the intensive care unit on postoperative day 1 and 2. On postoperative day 9 patient reported left upper-quadrant pain; computed tomography scan showed a small splenic infarct managed nonoperatively with analgesia and a short antibiotic course. Discharged day was on postoperative day 16. Final pathology reported moderately differentiated PDAC with high-grade PanIN, lymphovascular, and perineural invasion, peripancreatic fat infiltration; 6/26 nodes were positive (ypT3 N2) and 6 nodes with non-necrotizing granulomas. Margins were negative. Spleen-preserving total duodenopancreatectomy can achieve oncologic clearance but poses technical challenges and splenic ischemia risk that can be managed with non-invasive approach. Feasible for select centrally located PDACs with meticulous vascular technique and vigilant follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.